Alps Advisors Inc Athenex, Inc. Transaction History

Alps Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 25, 2018	SELL	$15.88 - $19.5 $311,390 - $382,375	-19,609 Reduced 23.38%	64,265 $1.02 Million
Q1 2018 May 01, 2018	BUY	$13.53 - $17.47 $265,309 - $342,569	19,609 Added 30.51%	83,874 $1.43 Million
Q4 2017 Feb 05, 2018	BUY	$14.41 - $19.15 $926,058 - $1.23 Million	64,265	64,265 $1.02 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.